Suppr超能文献

相似文献

1
Identification of Covalent Cyclic Peptide Inhibitors in mRNA Display.
J Am Chem Soc. 2023 Jul 19;145(28):15065-15070. doi: 10.1021/jacs.3c04833. Epub 2023 Jul 3.
2
Genetically Encoded Cyclic Peptide Libraries: From Hit to Lead and Beyond.
Methods Enzymol. 2018;610:117-134. doi: 10.1016/bs.mie.2018.09.020. Epub 2018 Oct 24.
3
The Construction of a Genetically Encoded, Phage-Displayed Cyclic-Peptide Library.
Methods Mol Biol. 2021;2355:219-230. doi: 10.1007/978-1-0716-1617-8_17.
4
Cyclic Peptide Screening Methods for Preclinical Drug Discovery.
J Med Chem. 2022 Sep 22;65(18):11913-11926. doi: 10.1021/acs.jmedchem.2c01077. Epub 2022 Sep 8.
5
A Genetically Encoded, Phage-Displayed Cyclic-Peptide Library.
Angew Chem Int Ed Engl. 2019 Oct 28;58(44):15904-15909. doi: 10.1002/anie.201908713. Epub 2019 Sep 9.
6
Discovery of Thioether-Cyclized Macrocyclic Covalent Inhibitors by mRNA Display.
J Am Chem Soc. 2024 Aug 28;146(34):24053-24060. doi: 10.1021/jacs.4c07851. Epub 2024 Aug 13.
7
mRNA Display in Cell Lysates Enables Identification of Cyclic Peptides Targeting the BRD3 Extraterminal Domain.
Angew Chem Int Ed Engl. 2024 Sep 16;63(38):e202406414. doi: 10.1002/anie.202406414. Epub 2024 Aug 14.
8
Enzymatic Macrolactamization of mRNA Display Libraries for Inhibitor Selection.
ACS Chem Biol. 2023 Jan 20;18(1):166-175. doi: 10.1021/acschembio.2c00828. Epub 2022 Dec 9.
9
Comparison of mRNA-display-based selections using synthetic peptide and natural protein libraries.
Biochemistry. 2007 Sep 4;46(35):10102-12. doi: 10.1021/bi700220x. Epub 2007 Aug 9.
10
Directing evolution of novel ligands by mRNA display.
Chem Soc Rev. 2021 Aug 21;50(16):9055-9103. doi: 10.1039/d1cs00160d. Epub 2021 Jun 24.

引用本文的文献

2
From Concepts to Inhibitors: A Blueprint for Targeting Protein-Protein Interactions.
Chem Rev. 2025 Jul 23;125(14):6819-6869. doi: 10.1021/acs.chemrev.5c00046. Epub 2025 Jun 24.
3
An Intracellular Peptide Library Screening Platform Identifies Irreversible Covalent Transcription Factor Inhibitors.
Adv Sci (Weinh). 2025 May;12(18):e2416963. doi: 10.1002/advs.202416963. Epub 2025 Mar 17.
4
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines.
Signal Transduct Target Ther. 2025 Mar 5;10(1):74. doi: 10.1038/s41392-024-02107-5.
5
An mRNA Display Approach for Covalent Targeting of a Virulence Factor.
J Am Chem Soc. 2025 Mar 12;147(10):8312-8325. doi: 10.1021/jacs.4c15713. Epub 2025 Feb 27.
6
Late-Stage Reshaping of Phage-Displayed Libraries to Macrocyclic and Bicyclic Landscapes using a Multipurpose Linchpin.
J Am Chem Soc. 2025 Jan 8;147(1):789-800. doi: 10.1021/jacs.4c13561. Epub 2024 Dec 19.
8
An mRNA Display Approach for Covalent Targeting of a Virulence Factor.
bioRxiv. 2024 Nov 8:2024.11.06.622387. doi: 10.1101/2024.11.06.622387.
9
Tackling Undruggable Targets with Designer Peptidomimetics and Synthetic Biologics.
Chem Rev. 2024 Nov 27;124(22):13020-13093. doi: 10.1021/acs.chemrev.4c00423. Epub 2024 Nov 14.
10
Selection of Nucleotide-Encoded Mass Libraries of Macrocyclic Peptides for Inaccessible Drug Targets.
Chem Rev. 2024 Nov 13;124(21):12213-12241. doi: 10.1021/acs.chemrev.4c00422. Epub 2024 Oct 25.

本文引用的文献

1
Enabling Genetic Code Expansion and Peptide Macrocyclization in mRNA Display via a Promiscuous Orthogonal Aminoacyl-tRNA Synthetase.
J Am Chem Soc. 2023 Jan 25;145(3):1512-1517. doi: 10.1021/jacs.2c11294. Epub 2023 Jan 11.
2
De Novo Discovery of Thiopeptide Pseudo-natural Products Acting as Potent and Selective TNIK Kinase Inhibitors.
J Am Chem Soc. 2022 Nov 9;144(44):20332-20341. doi: 10.1021/jacs.2c07937. Epub 2022 Oct 25.
3
Triazine-Based Covalent DNA-Encoded Libraries for Discovery of Covalent Inhibitors of Target Proteins.
ACS Med Chem Lett. 2022 Aug 15;13(10):1574-1581. doi: 10.1021/acsmedchemlett.2c00127. eCollection 2022 Oct 13.
4
mRNA Display Reaches for the Clinic with New PCSK9 Inhibitor.
ACS Med Chem Lett. 2022 Aug 26;13(9):1379-1383. doi: 10.1021/acsmedchemlett.2c00319. eCollection 2022 Sep 8.
5
Advances in covalent drug discovery.
Nat Rev Drug Discov. 2022 Dec;21(12):881-898. doi: 10.1038/s41573-022-00542-z. Epub 2022 Aug 25.
6
Lysine-Targeted Reversible Covalent Ligand Discovery for Proteins via Phage Display.
J Am Chem Soc. 2022 Aug 31;144(34):15885-15893. doi: 10.1021/jacs.2c07375. Epub 2022 Aug 17.
7
Discovery and Structural Basis of the Selectivity of Potent Cyclic Peptide Inhibitors of MAGE-A4.
J Med Chem. 2022 May 26;65(10):7231-7245. doi: 10.1021/acs.jmedchem.2c00185. Epub 2022 May 6.
8
Discovery and Development of Cyclic Peptide Inhibitors of CIB1.
ACS Med Chem Lett. 2021 Oct 27;12(11):1832-1839. doi: 10.1021/acsmedchemlett.1c00438. eCollection 2021 Nov 11.
9
A Series of Novel, Highly Potent, and Orally Bioavailable Next-Generation Tricyclic Peptide PCSK9 Inhibitors.
J Med Chem. 2021 Nov 25;64(22):16770-16800. doi: 10.1021/acs.jmedchem.1c01599. Epub 2021 Oct 27.
10
Sotorasib for Lung Cancers with p.G12C Mutation.
N Engl J Med. 2021 Jun 24;384(25):2371-2381. doi: 10.1056/NEJMoa2103695. Epub 2021 Jun 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验